##fileformat=VCFv4.1
##INFO=<ID=CONSEQUENCE,Number=.,Type=String,Description="Mutation consequence predictions annotated by SnpEff (subfields: gene_symbol|gene_affected|gene_strand|transcript_name|transcript_affected|protein_affected|consequence_type|cds_mutation|aa_mutation)">
##INFO=<ID=OCCURRENCE,Number=.,Type=String,Description="Mutation occurrence counts broken down by project (subfields: project_code|affected_donors|tested_donors|frequency)">
##INFO=<ID=affected_donors,Number=1,Type=Integer,Description="Number of donors with the current mutation">
##INFO=<ID=mutation,Number=1,Type=String,Description="Somatic mutation definition">
##INFO=<ID=project_count,Number=1,Type=Integer,Description="Number of projects with the current mutation">
##INFO=<ID=tested_donors,Number=1,Type=Integer,Description="Total number of donors with SSM data available">
##comment=ICGC open access Simple Somatic Mutations (SSM) data dump in VCF format
##fileDate=2016-08-16T16:32:17.882-04:00
##geneModel=ENSEMBL75
##reference=GRCh37
##source=ICGC22-12
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	100000022	MU39532371	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100000181	MU259333	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100000340	MU64917116	AGGAATAGGGTGGGTCTGTGGCATTTAATCAGCGG	AGTATAGAGTGTAAAGAGT	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=AGGAATAGGGTGGGTCTGTGGCATTTAATCAGCGG>AGTATAGAGTGTAAAGAGT;project_count=1;tested_donors=10638
1	100000409	MU1214865	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100000520	MU66254099	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100000600	MU51657082	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100000874	MU47372259	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100000914	MU55517265	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100000961	MU17650851	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	10000103	MU43972879	G	A	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100001284	MU66543626	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100001398	MU3929060	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=RECA-EU|1|95|0.01053;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100001471	MU4811959	GCCTAACTTCCTGGC	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=CCTAACTTCCTGGC>-;project_count=1;tested_donors=10638
1	100001565	MU43111470	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>C;project_count=1;tested_donors=10638
1	100001783	MU4631949	C	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100001852	MU58887544	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100002104	MU32523431	TTGCCTTAAAAAATAATGTATTCAAG	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=TGCCTTAAAAAATAATGTATTCAAG>-;project_count=1;tested_donors=10638
1	100002188	MU36319710	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100002261	MU68005356	G	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ORCA-IN|1|131|0.00763;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100002298	MU4811981	C	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100002302	MU11131969	C	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-CA|1|259|0.00386;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100002362	MU54632962	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100002893	MU54198231	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100002940	MU67631116	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ORCA-IN|1|131|0.00763;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100003025	MU38544509	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100003076	MU48723131	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	10000308	MU59803200	C	T	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100003086	MU50049571	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100003158	MU27361829	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100003330	MU61337377	T	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100003437	MU365324	T	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100003493	MU38089270	A	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=A>C;project_count=1;tested_donors=10638
1	100003569	MU28939469	GA	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-CA|1|259|0.00386;affected_donors=1;mutation=A>-;project_count=1;tested_donors=10638
1	100003614	MU44245003	T	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100003615	MU49193738	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100003620	MU41307031	A	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
1	100003665	MU66840669	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100003683	MU29846696	A	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PAEN-AU|1|52|0.01923;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100003823	MU37823168	GT	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>-;project_count=1;tested_donors=10638
1	10000394	MU69443547	C	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=MALY-DE|1|100|0.01000;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100003945	MU28822249	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100004072	MU54129238	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100004105	MU56882215	T	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100004146	MU53130823	G	A	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100004209	MU51795369	G	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>T;project_count=1;tested_donors=10638
1	100004217	MU47376103	C	G	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100004291	MU4812008	G	C	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100004483	MU51081961	TA	AC	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=TA>AC;project_count=1;tested_donors=10638
1	100004499	MU1617685	C	T	.	.	CONSEQUENCE=||||||intergenic_region||,RP11-413P11.1|ENSG00000224445|1|RP11-413P11.1-001|ENST00000438829||upstream_gene_variant||;OCCURRENCE=MALY-DE|1|100|0.01000;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100004681	MU36319723	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100004738	MU64607288	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005040	MU56766088	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005091	MU29372656	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100005234	MU53612832	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100005240	MU46206398	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005246	MU32319144	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100005301	MU45609969	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100005358	MU68498541	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-FR|1|64|0.01563;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100005465	MU48073637	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005474	MU63682567	C	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100005477	MU11131942	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PBCA-DE|1|380|0.00263;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100005551	MU55272376	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100005629	MU32950170	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100005652	MU1554213	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MALY-DE|1|100|0.01000;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005669	MU58362293	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	10000567	MU67774571	A	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=LAML-KR|1|117|0.00855;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100005738	MU66052521	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100005921	MU62566525	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10000596	MU19060779	T	A	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-004|ENST00000488540||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100005994	MU55262197	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100006222	MU42778683	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100006233	MU4812024	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100006234	MU64656579	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100006288	MU46640708	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100006906	MU57573364	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100006969	MU49283240	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10000701	MU67912406	C	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100007091	MU56169439	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007092	MU68235467	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PBCA-DE|1|380|0.00263;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100007225	MU4631957	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100007387	MU54113859	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100007489	MU49149204	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007504	MU34733576	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007649	MU41000953	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100007734	MU62116333	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100007835	MU15779791	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100007893	MU36253242	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007936	MU33333427	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007957	MU46267652	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007958	MU64791261	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100007990	MU4626590	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PAEN-AU|1|52|0.01923;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100008212	MU28770474	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100008323	MU62282940	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100008327	MU41785269	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100008433	MU28471991	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BOCA-FR|1|98|0.01020;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100008567	MU63640121	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100008594	MU4631959	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
1	100008625	MU60412982	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100008719	MU63232434	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LUSC-KR|1|66|0.01515;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100008792	MU41903826	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100008795	MU42583515	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100008883	MU46889936	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100008900	MU61694347	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10000892	MU40220207	C	T	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100008945	MU30898938	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100008947	MU28972582	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100009189	MU40222609	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100009215	MU38058476	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100009383	MU56136383	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100009447	MU33333440	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100009516	MU3171982	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100009609	MU35112848	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100009682	MU63473921	C	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100009822	MU53854546	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LUSC-KR|1|66|0.01515;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100009846	MU54498439	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100009950	MU58412913	A	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>C;project_count=1;tested_donors=10638
1	100009959	MU41122739	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100010031	MU32506837	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PACA-CA|1|259|0.00386;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
1	100010069	MU59237827	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100010154	MU51232220	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100010163	MU58422951	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100010224	MU38119132	AT	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>-;project_count=1;tested_donors=10638
1	100010317	MU51540217	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100010319	MU53875545	A	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=A>C;project_count=1;tested_donors=10638
1	100010325	MU39532373	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100010454	MU37584729	T	TC	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=->C;project_count=1;tested_donors=10638
1	100010475	MU68392838	G	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MALY-DE|1|100|0.01000;affected_donors=1;mutation=G>T;project_count=1;tested_donors=10638
1	100010926	MU30185392	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PAEN-IT|1|37|0.02703;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10001094	MU35288356	T	C	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	10001097	MU64539401	AT	A	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=T>-;project_count=1;tested_donors=10638
1	100010989	MU11131973	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PACA-CA|1|259|0.00386;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100011051	MU70144207	C	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100011095	MU69089121	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MALY-DE|1|100|0.01000;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100011156	MU51617653	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100011234	MU46274697	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10001126	MU70096608	C	T	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100011441	MU36319736	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100011731	MU56130780	G	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LUSC-KR|1|66|0.01515;affected_donors=1;mutation=G>T;project_count=1;tested_donors=10638
1	100011882	MU34536083	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|2|203|0.00985;affected_donors=2;mutation=A>T;project_count=1;tested_donors=10638
1	100012002	MU46322739	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100012156	MU55668955	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100012177	MU57744721	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100012193	MU43957704	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100012334	MU45563137	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	10001247	MU4631974	G	T	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=PBCA-DE|8|380|0.02105,MALY-DE|2|100|0.02000,LIRI-JP|1|258|0.00388;affected_donors=11;mutation=G>T;project_count=3;tested_donors=10638
1	10001255	MU42250516	T	C	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=BTCA-JP|1|239|0.00418;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100012653	MU49497531	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100012664	MU47003985	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100012689	MU4626662	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=OV-AU|1|93|0.01075;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100012705	MU41850698	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100012763	MU55208258	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	10001286	MU66369051	C	G	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
1	100012862	MU47474644	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100012912	MU4626663	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=OV-AU|1|93|0.01075;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100012990	MU64010901	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100013085	MU365329	T	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=T>G;project_count=1;tested_donors=10638
1	100013089	MU52894659	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493,MELA-AU|2|183|0.01093;affected_donors=3;mutation=C>T;project_count=2;tested_donors=10638
1	100013211	MU62984970	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100013250	MU35443932	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100013295	MU61004684	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100013397	MU32064675	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-CA|1|124|0.00806;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
1	100013646	MU62630814	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100013775	MU57135927	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100013864	MU4631981	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LIRI-JP|1|258|0.00388;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
1	100013949	MU43028093	TG	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>-;project_count=1;tested_donors=10638
1	100013951	MU37769058	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100013952	MU37769064	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100013974	MU48153165	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100014175	MU65487860	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179,BRCA-FR|1|64|0.01563;affected_donors=2;mutation=G>C;project_count=2;tested_donors=10638
1	100014288	MU4626667	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=OV-AU|1|93|0.01075;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100014465	MU67310527	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100014476	MU62775134	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100014510	MU47561418	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100014514	MU63330500	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LUSC-KR|1|66|0.01515;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
1	100014763	MU39031357	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100014828	MU30462081	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-UK|1|108|0.00926;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
1	100014860	MU65282800	A	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179,BRCA-FR|1|64|0.01563;affected_donors=2;mutation=A>C;project_count=2;tested_donors=10638
1	100014884	MU70648057	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=ESAD-UK|1|203|0.00493;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
1	100014983	MU44494304	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100015151	MU54409695	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	1000152	MU58295107	C	T	.	.	CONSEQUENCE=RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-002|ENST00000394517||intron_variant||,RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-001|ENST00000412397||intron_variant||,RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-005|ENST00000427998||intron_variant||,RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-003|ENST00000433695||intron_variant||,RP11-54O7.18|ENSG00000273443|1|RP11-54O7.18-001|ENST00000442292||upstream_gene_variant||,RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-004|ENST00000451054||intron_variant||,RP11-465B22.3|ENSG00000217801|+|RP11-465B22.3-006|ENST00000456409||intron_variant||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
1	100015430	MU51024954	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	10001558	MU54716123	CT	C	.	.	CONSEQUENCE=NMNAT1|ENSG00000173614|+|NMNAT1-001|ENST00000377205||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-005|ENST00000377213||intron_variant||,LZIC|ENSG00000162441|1|LZIC-001|ENST00000377223||intron_variant||,LZIC|ENSG00000162441|1|LZIC-201|ENST00000400903||intron_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-002|ENST00000403197||upstream_gene_variant||,RP11-84A14.4|ENSG00000228150|+|RP11-84A14.4-001|ENST00000445884||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-005|ENST00000462686||upstream_gene_variant||,NMNAT1|ENSG00000173614|+|NMNAT1-004|ENST00000492735||upstream_gene_variant||,LZIC|ENSG00000162441|1|LZIC-202|ENST00000541052||intron_variant||;OCCURRENCE=LICA-FR|1|240|0.00417;affected_donors=1;mutation=T>-;project_count=1;tested_donors=10638
1	100015589	MU54773967	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100015829	MU65698738	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100015949	MU47013458	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
1	100016013	MU67249181	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=BRCA-EU|1|560|0.00179;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9997022	MU43227982	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9997052	MU44708622	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=C>T;project_count=1;tested_donors=10638
Y	9997055	MU44708695	A	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=A>C;project_count=1;tested_donors=10638
Y	9997057	MU44708724	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=G>C;project_count=1;tested_donors=10638
Y	9997059	MU4221857	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070,RECA-EU|1|95|0.01053;affected_donors=3;mutation=A>T;project_count=2;tested_donors=10638
Y	9997062	MU16400970	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PACA-AU|1|391|0.00256;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
Y	9997096	MU44708816	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=C>T;project_count=1;tested_donors=10638
Y	9997100	MU34710410	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
Y	9997140	MU43871823	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=A>G;project_count=1;tested_donors=10638
Y	9997142	MU57497329	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
Y	9997145	MU4001411	A	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|2|70|0.02857;affected_donors=2;mutation=A>G;project_count=1;tested_donors=10638
Y	9997147	MU34710428	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|2|70|0.02857;affected_donors=2;mutation=A>T;project_count=1;tested_donors=10638
Y	9997152	MU4284820	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=RECA-EU|1|95|0.01053;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
Y	9997162	MU34710447	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|2|70|0.02857;affected_donors=2;mutation=C>A;project_count=1;tested_donors=10638
Y	9997194	MU45695488	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9997212	MU45695560	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9997256	MU45695631	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9997262	MU44708896	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=G>C;project_count=1;tested_donors=10638
Y	9997290	MU48332405	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9997376	MU44708953	A	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=A>C;project_count=1;tested_donors=10638
Y	9997392	MU61320287	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9997393	MU44709024	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=C>T;project_count=1;tested_donors=10638
Y	9997400	MU34710460	G	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>T;project_count=1;tested_donors=10638
Y	9997426	MU40391994	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
Y	9997431	MU40391996	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
Y	9997442	MU44709088	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|2|187|0.01070;affected_donors=2;mutation=G>A;project_count=1;tested_donors=10638
Y	9997451	MU15316252	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9997452	MU40391998	T	TGA	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=->GA;project_count=1;tested_donors=10638
Y	9997453	MU67425876	G	GA	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PBCA-DE|2|380|0.00526,MALY-DE|1|100|0.01000;affected_donors=3;mutation=->A;project_count=2;tested_donors=10638
Y	9997459	MU40392000	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
Y	9997471	MU46052595	CC	TT	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=CC>TT;project_count=1;tested_donors=10638
Y	9997472	MU15316304	C	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=C>A;project_count=1;tested_donors=10638
Y	9997493	MU35274516	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9997502	MU15316381	A	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=A>T;project_count=1;tested_donors=10638
Y	9997573	MU43871898	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9997604	MU43871975	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
Y	9997630	MU67989961	CTAAACA	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PBCA-DE|1|380|0.00263,MALY-DE|1|100|0.01000;affected_donors=2;mutation=TAAACA>-;project_count=2;tested_donors=10638
Y	9997768	MU42474604	G	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=G>C;project_count=1;tested_donors=10638
Y	9997795	MU43228049	T	C	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=T>C;project_count=1;tested_donors=10638
Y	9997869	MU49279319	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9998170	MU33512431	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=SKCA-BR|1|70|0.01429;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9998658	MU47964056	C	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LUSC-KR|1|66|0.01515;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
Y	9998686	MU49565549	T	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=LICA-FR|1|240|0.00417;affected_donors=1;mutation=T>A;project_count=1;tested_donors=10638
Y	9998874	MU59611256	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|2|183|0.01093;affected_donors=2;mutation=G>A;project_count=1;tested_donors=10638
Y	9998940	MU42580058	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=MELA-AU|1|183|0.00546;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9999139	MU63623967	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PACA-CA|1|259|0.00386;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9999237	MU30503112	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=PRAD-CA|1|124|0.00806;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
Y	9999399	MU44709162	C	G	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>G;project_count=1;tested_donors=10638
Y	9999421	MU44709239	G	A	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=G>A;project_count=1;tested_donors=10638
Y	9999457	MU44709280	C	T	.	.	CONSEQUENCE=||||||intergenic_region||;OCCURRENCE=COCA-CN|1|187|0.00535;affected_donors=1;mutation=C>T;project_count=1;tested_donors=10638
